WuXi XDC Cayman Inc (hkse:02268) Share Price

Company Profile

Business description
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
Contact
No. 11 Xinhui Ring Road
Xinwu
Jiangsu Province
Wuxi
CHN
https://www.wuxixdc.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
2,270

Recommended

The ASX, known for its yield appeal is at its lowest level in 20 years. Here’s why, and what investors should do.

Steve Lambeth | 02 February 2026

We’ve raised our fair value estimate of Exxon stock.

Allen Good, CFA | 02 February 2026

Growth in areas critical to the firm’s future.

Matthew Dolgin, CFA | 02 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,149.30	6.90	-0.08%
CAC 40	8,138.17	43.00	-0.53%
DAX 40	24,757.85	39.67	-0.16%
Dow JONES (US)	49,407.66	515.19	1.05%
FTSE 100	10,240.25	101.31	-0.98%
HKSE	26,834.77	59.20	0.22%
NASDAQ	23,592.11	130.29	0.56%
Nikkei 225	54,720.66	2,065.48	3.92%
NZX 50 Index	13,421.52	9.08	0.07%
S&P 500	6,976.44	0.00	0.00%
S&P/ASX 200	8,857.10	9.20	-0.10%
SSE Composite Index	4,067.74	51.99	1.29%